Back to Best of AC17 Session - Opioids for Cancer Pain: Pursuing Balance - On-Demand
Best of AC17 Session - Opioids for Cancer Pain: Pursuing Balance - On-Demand

Best of AC17 Session - Opioids for Cancer Pain: Pursuing Balance - On-Demand

Recent public health concerns have arisen concerning the use of prescription opioids in the United States. Although they are mostly focused on nonmalignant pain, oncology practitioners should be aware of these issues and how they may affect their own practice. We will discuss potential strategies for appropriate opioid use in the cancer pain population.

Content Area: Patient Management & Therapeutics

Product Details

Session from HOPA 2017 Annual Conference

Opioids for Cancer Pain: Pursuing Balance

Speaker: Julie Waldfogel, PharmD CPE

Learning Objectives:

1.      Review recent guidelines for opioid use in both nonmalignant and malignant pain populations.

2.      Discuss risk assessment tools for monitoring patients on opioids.

3.      Review data on long-term benefits and risks of opioid use.

 

  • List Price: $35.00 USD
  • Member Price: $25.00 USD
Join and Save!
Log into see if you qualify for a lower price.
HOPA members save $10.00 USD or more!
Become a member